AmacaThera announces $10.3 million raise, featured in Globe and Mail

Ontario Industry Updates
Written By Maura Campbell
AmacaThera.jpg

AmacaThera, a 2017 OBIO CAAP company who presented at the 2018 OBIO Investment Summit, has raised $10.3 million and was featured in the Globe and Mail. The funds will be used to take their injectable gel product that can improve post-surgery pain treatment into human safety trials this year.

Maura Campbell
Previous

Felix Health Raises $10 Million
Next

OBIO Investment Summit Showcases Canada’s Booming Health Science Industry on the World Stage